Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegamotecan in Advanced or Metastatic Soft Tissue Sarcoma
NCT00079950Phase 2Suspended
- Sponsor
- Enzon Pharmaceuticals
- Start
- Aug 2003
- Modality
- Polymer-based Nanoparticles, Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of pegamotecan in soft tissue sarcoma (STS), sponsored by Enzon Pharmaceuticals. Started Aug 2003; status: suspended.
02
Drugs
pegamotecan
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00079950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079950.